Uses AI to engineer AAV capsids as improved gene-delivery vectors, licensing designs to major pharma.
Builds large language models for protein design and created OpenCRISPR-1, the first AI-generated gene editor.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →